Biotech CEOs are now more concerned about insurers than the Food and Drug Administration's regulatory process, reports Luke Zimmerman at Xconomy, drawing on a new survey put out by BayBio, the California Healthcare Institute, and PwC of 157 biotech CEOs in California.
Registering provides access to this and other free content.
Already have an account?Login Now.
In PLOS this week: researchers explore the transfer of host genetic material into viruses, and more.
It's too difficult to correct or retract a flawed scientific paper, researchers write in Nature.
A proposed bill would require NSF to only fund research that's in "the national interest."
Australia's Commonwealth Scientific and Industrial Research Organisation plans to eliminate up to 350 jobs.